Baker Bros. Advisors »

Ptc Therapeutics I shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $921k 20k 45.14

More positions owned by Baker Bros. Advisors

BeOne Medicines Sponsored Ads (ONC)
Incyte Corporation (INCY)
Madrigal Pharmaceuticals (MDGL)
Insmed Incorporated Com Par $.01 (INSM)
ACADIA Pharmaceuticals (ACAD)
Summit Therapeutics (SMMT)
Rhythm Pharmaceuticals (RYTM)
Revolution Medicines (RVMD)
Celcuity (CELC)
Kymera Therapeutics (KYMR)
Kodiak Sciences (KOD)
Alkermes SHS (ALKS)
Abcellera Biologics (ABCL)
Edgewise Therapeutics (EWTX)
Kiniksa Pharmaceuticals International Ord Shs Cl A (KNSA)

View all positions for Baker Bros. Advisors

Top funds holding Ptc Therapeutics I

Vanguard Group
Rtw Investments
BlackRock
Wellington Management Company
Henderson Group
Armistice Capital
Toronto-Dominion Bank
State Street Corporation
D. E. Shaw & Co
Geode Capital Management
Citadel Advisors
FMR
Leucadia National Corporation
Tang Capital Management
Pictet Asset Management Holding SA

View all funds holding Ptc Therapeutics I